A Phase I/II trial to evaluate gefitinib and concurrent postoperative chemoradiation in patients with advanced resectable head and neck cancer.
Phase of Trial: Phase I/II
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Gefitinib (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2011 New trial record